s decision.

2 trials

Sponsors

Tokyo Medical and Dental University, North Japan Lung Cancer Study Group

Conditions

Non-small cell lung cancerRheumatic diseases

Phase 2

Randomized phase II trial of Carboplatin plus weekly nab-Paclitaxel versus Cisplatin plus Gemcitabine in patients with chemo-naive stage IIIB/IV or postoperative recurrent squamous cell lung cancer

Active, not recruitingJPRN-UMIN000010443

North Japan Lung Cancer Study GroupNon-small cell lung cancer

Start: 2013-05-17Target: 70Updated: 2026-06-29

Unknown Phase

A randomized clinical trial on the efficacy and tolerability of dose reduction and escalation regimen of Trimethoprim/Sulfamethoxazole (TMP/SMX) in patients with rheumatic diseases

Active, not recruitingJPRN-UMIN000007727

Tokyo Medical and Dental UniversityRheumatic diseases

Start: 2012-05-01Target: 165Updated: 2026-06-29

Related Papers

An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up

Rheumatology Advances in Practice2020-01-0116 citations

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial

Arthritis Research & Therapy2017-01-1853 citations